Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Paula B. van Hennik"'
Autor:
Jorn Mulder, Odile C. van Stuijvenberg, Paula B. van Hennik, Emile E. Voest, Anna M. G. Pasmooij, Violeta Stoyanova-Beninska, Anthonius de Boer
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
There are currently four anti-cancer medicinal products approved for a tissue-agnostic indication. This is an indication based on a common biological characteristic rather than the tissue of origin. To date, the regulatory experience with tissue-agno
Externí odkaz:
https://doaj.org/article/bef9992941e84c2bb5b56da3c1c101f1
Autor:
Gabe S Sonke, Amos J de Jong, Lourens T Bloem, Christine C van Hattem, Jolien S de Groot, Jarno Hoekman, K Esther Broekman, Paula B van Hennik
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Objective The collection of comprehensive data from post-authorisation trials for conditionally authorised anticancer medicines is frequently delayed. This raises questions about the feasibility of post-authorisation randomised controlled trials (RCT
Externí odkaz:
https://doaj.org/article/4fe87bd87ee346fdb277817cb56dabf2
Autor:
Lourens T. Bloem, Jasmin Schelhaas, Lucía López‐Anglada, Carla Herberts, Paula B. van Hennik, Olli Tenhunen
Since 2006, the European conditional marketing authorization (CMA) aims to facilitate timely patient access to medicinal products for which there is an unmet medical need by accepting less comprehensive data than normally required. The granting of CM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4135e212be33e6200812c4b1f281a967
https://dspace.library.uu.nl/handle/1874/429487
https://dspace.library.uu.nl/handle/1874/429487
Autor:
C Mircea S Tesileanu, Sotirios Michaleas, Rocio Gonzalo Ruiz, Segundo Mariz, Babs O Fabriek, Paula B van Hennik, Jutta Dedorath, Bruna Dekic, Christoph Unkrig, Andreas Brandt, Janet Koenig, Harald Enzmann, Julio Delgado, Francesco Pignatti
Publikováno v:
The Oncologist.
Asciminib is an allosteric high-affinity tyrosine kinase inhibitor (TKI) of the BCR-ABL1 protein kinase. This kinase is translated from the Philadelphia chromosome in chronic myeloid leukemia (CML). Marketing authorization for asciminib was granted o
Autor:
Paula B. van Hennik, Peter L. Hordijk
Publikováno v:
Van Hennik, P B & Hordijk, P L 2005, ' Rho GTPases in hematopoietic cells ', Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1440-1455 . https://doi.org/10.1089/ars.2005.7.1440
The ubiquitous Rho GTPases are instrumental in the organization of the actin cytoskeleton, but also for the control of gene expression. Here we review the role of the major members of this family, i.e., RhoA, Rac1, Rac2, and Cdc42, and their intracel
Autor:
Sigrid P M A Oomen, Paula B. van Hennik, Leo J. Hofland, Ivo P. Touw, Steven W. J. Lamberts, Claudia Antonissen, Bob Löwenberg, Elgin G. R. Lichtenauer-Kaligis
Publikováno v:
Experimental Hematology, 30(2), 116-125. Elsevier Inc.
Objective Somatostatin (SST) is a regulatory peptide with a wide variety of activities in different tissues. SST activates G αi -protein-coupled receptors of a family comprising five members (SSTR1–5). Despite the broad use of SST and its analogs
Autor:
Martin R. Schipperus, Ineke Slaper-Cortenbach, Dimitri Breems, Nuray Kusadasi, Paula B. van Hennik, Hans van der Lelie, Henk van den Berg, Rob E. Ploemacher, Jan J. Cornelissen
Publikováno v:
British Journal of Haematology. 111:674-684
Autor:
Ana Limón, Jose A. Cancelas, Paula B. van Hennik, Gerard Wagemaker, Rob E. Ploemacher, A. W. Wognum, Marti F.A. Bierhuizen, Monique M A Verstegen, Jordi Barquinero
Publikováno v:
Blood, 92(11), 4013-4022. American Society of Hematology
Purified CD34+ and CD34+CD38− human umbilical cord blood (UCB) cells were transduced with the recombinant variant of Moloney murine leukemia virus (MoMLV) MFG-EGFP or with SF-EGFP, in which EGFP expression is driven by a hybrid promoter of the sple
Autor:
Nico van Rooijen, Wim Terpstra, Paula B. van Hennik, Rob E. Ploemacher, Gerard Wagemaker, Jenne J. Wielenga, Cor van den Bos, Monique M A Verstegen, Albertus W. Wognum
Publikováno v:
Blood, 91(6), 1966-1976. American Society of Hematology
In vivo expansion and multilineage outgrowth of human immature hematopoietic cell subsets from umbilical cord blood (UCB) were studied by transplantation into hereditary immunodeficient (SCID) mice. The mice were preconditioned with Cl2MDP-liposomes
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68477 (2013)
PLoS ONE
PLoS ONE, 8(7). Public Library of Science
Zoughlami, Y, van Stalborgh, A M, van Hennik, P B & Hordijk, P L 2013, ' Nucleophosmin1 Is a Negative Regulator of the Small GTPase Rac1 ', PLoS ONE, vol. 8, no. 7, e68477 . https://doi.org/10.1371/journal.pone.0068477
PLoS ONE, 8(7):e68477. Public Library of Science
PLoS ONE
PLoS ONE, 8(7). Public Library of Science
Zoughlami, Y, van Stalborgh, A M, van Hennik, P B & Hordijk, P L 2013, ' Nucleophosmin1 Is a Negative Regulator of the Small GTPase Rac1 ', PLoS ONE, vol. 8, no. 7, e68477 . https://doi.org/10.1371/journal.pone.0068477
PLoS ONE, 8(7):e68477. Public Library of Science
The Rac1 GTPase is a critical regulator of cytoskeletal dynamics and controls many biological processes, such as cell migration, cell-cell contacts, cellular growth and cell division. These complex processes are controlled by Rac1 signaling through e